S
Sigve Nakken
Researcher at University of Oslo
Publications - 63
Citations - 2387
Sigve Nakken is an academic researcher from University of Oslo. The author has contributed to research in topics: Cancer & Lynch syndrome. The author has an hindex of 19, co-authored 54 publications receiving 1696 citations. Previous affiliations of Sigve Nakken include Oslo University Hospital & Rikshospitalet–Radiumhospitalet.
Papers
More filters
Journal ArticleDOI
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pål Møller,Toni T. Seppälä,Inge Bernstein,Inge Bernstein,Elke Holinski-Feder,Paola Sala,D. Gareth Evans,Annika Lindblom,Finlay A. Macrae,Finlay A. Macrae,Ignacio Blanco,Rolf H. Sijmons,Jacqueline Jeffries,Hans F. A. Vasen,John Burn,Sigve Nakken,Eivind Hovig,Einar Andreas Rødland,Kukatharmini Tharmaratnam,Wouter H. de Vos tot Nederveen Cappel,James A. Hill,Juul T. Wijnen,Kate Green,Fiona Lalloo,Lone Sunde,Lone Sunde,Miriam Mints,Lucio Bertario,Marta Pineda,Matilde Navarro,Monika Morak,Laura Renkonen-Sinisalo,Ian M. Frayling,John-Paul Plazzer,Kirsi Pylvänäinen,Julian R. Sampson,Gabriel Capellá,Jukka-Pekka Mecklin,Gabriela Möslein +38 more
TL;DR: The four Lynch syndrome-associated genes had different penetrance and expression, and colorectal cancer occurred frequently despite colonoscopic surveillance but resulted in few deaths.
Journal ArticleDOI
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Pål Møller,Toni T. Seppälä,Inge Bernstein,Inge Bernstein,Elke Holinski-Feder,Paulo Sala,D. Gareth Evans,D. Gareth Evans,Annika Lindblom,Finlay A. Macrae,Finlay A. Macrae,Ignacio Blanco,Rolf H. Sijmons,Jacqueline Jeffries,Hans F. A. Vasen,John Burn,Sigve Nakken,Eivind Hovig,Einar Andreas Rødland,Kukatharmini Tharmaratnam,Wouter H. de Vos tot Nederveen Cappel,James Hill,Juul T. Wijnen,Mark A. Jenkins,Kate Green,Kate Green,Fiona Lalloo,Fiona Lalloo,Lone Sunde,Miriam Mints,Lucio Bertario,Marta Pineda,Matilde Navarro,Monika Morak,Laura Renkonen-Sinisalo,Laura Renkonen-Sinisalo,Mev Dominguez Valentin,Ian M. Frayling,John-Paul Plazzer,Kirsi Pylvänäinen,Maurizio Genuardi,Jukka-Pekka Mecklin,Gabriela Moeslein,Julian R. Sampson,Gabriel Capellá +44 more
TL;DR: Carriers of different path_MMR variants exhibit distinct patterns of cancer risk and survival as they age, and risk estimates for counselling and planning of surveillance and treatment should be tailored to each patient’s age, gender and path-MMR variant.
Journal ArticleDOI
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Mev Dominguez-Valentin,Julian R. Sampson,Toni T. Seppälä,Sanne W. ten Broeke,John-Paul Plazzer,Sigve Nakken,Christoph Engel,Stefan Aretz,Mark A. Jenkins,Lone Sunde,Lone Sunde,Inge Bernstein,Gabriel Capellá,Francesc Balaguer,Huw D. Thomas,D. Gareth Evans,D. Gareth Evans,John Burn,Marc S. Greenblatt,Eivind Hovig,Wouter H. de Vos tot Nederveen Cappel,Rolf H. Sijmons,Lucio Bertario,Maria Grazia Tibiletti,Giulia Martina Cavestro,Annika Lindblom,Adriana Della Valle,Francisco López-Köstner,Nathan Gluck,Lior H. Katz,Karl Heinimann,Carlos A. Vaccaro,Reinhard Büttner,Heike Görgens,Elke Holinski-Feder,Monika Morak,Stefanie Holzapfel,Robert Hüneburg,Magnus von Knebel Doeberitz,Magnus von Knebel Doeberitz,Markus Loeffler,Nils Rahner,Hans K. Schackert,Verena Steinke-Lange,Wolff Schmiegel,Deepak Vangala,Kirsi Pylvänäinen,Laura Renkonen-Sinisalo,Laura Renkonen-Sinisalo,John L. Hopper,Aung Ko Win,Robert W. Haile,Noralane M. Lindor,Steven Gallinger,Loic Le Marchand,Polly A. Newcomb,Jane C. Figueiredo,Stephen N. Thibodeau,Karin Wadt,Christina Therkildsen,Henrik Okkels,Zohreh Ketabi,Leticia Moreira,Ariadna Sánchez,Miquel Serra-Burriel,Marta Pineda,Matilde Navarro,Ignacio Blanco,Kate Green,Fiona Lalloo,Emma J Crosbie,James Hill,Oliver G. Denton,Ian M. Frayling,Einar Andreas Rødland,Hans F. A. Vasen,Miriam Mints,Florencia Neffa,Patricia Esperon,Karin Alvarez,Revital Kariv,Guy Rosner,Tamara Alejandra Piñero,María Laura Gonzalez,Pablo Kalfayan,Douglas Tjandra,Ingrid Winship,Ingrid Winship,Finlay A. Macrae,Finlay A. Macrae,Gabriela Möslein,Jukka-Pekka Mecklin,Maartje Nielsen,Pål Møller,Pål Møller +94 more
TL;DR: Management guidelines for Lynch syndrome may require revision in light of these different gene and gender-specific risks and the good prognosis for the most commonly associated cancers.
Journal ArticleDOI
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
Tyler Alioto,Ivo Buchhalter,Sophia Derdak,Barbara Hutter,Matthew D. Eldridge,Eivind Hovig,Lawrence E. Heisler,Timothy Beck,Jared T. Simpson,Laurie Tonon,Anne Sophie Sertier,Ann-Marie Patch,Ann-Marie Patch,Natalie Jäger,Natalie Jäger,Philip Ginsbach,Ruben M. Drews,Nagarajan Paramasivam,Rolf Kabbe,Sasithorn Chotewutmontri,Nicolle Diessl,Christopher Previti,Sabine Schmidt,Benedikt Brors,Lars Feuerbach,Michael Heinold,Susanne Gröbner,Andrey Korshunov,Patrick S. Tarpey,Adam Butler,Jonathan Hinton,David T. Jones,Andrew Menzies,Keiran Raine,Rebecca Shepherd,Lucy Stebbings,Jon W. Teague,Paolo Ribeca,Francesc Castro Giner,Sergi Beltran,Emanuele Raineri,Marc Dabad,Simon Heath,Marta Gut,Robert E. Denroche,Nicholas J. Harding,Takafumi N. Yamaguchi,Akihiro Fujimoto,Hidewaki Nakagawa,Víctor Quesada,Rafael Valdés-Mas,Sigve Nakken,Daniel Vodak,Lawrence Bower,Andy G. Lynch,Charlotte Anderson,Charlotte Anderson,Nicola Waddell,Nicola Waddell,John V. Pearson,John V. Pearson,Sean M. Grimmond,Sean M. Grimmond,Myron Peto,Paul T. Spellman,Minghui He,Cyriac Kandoth,Semin Lee,John Zhang,John Zhang,Louis Letourneau,Singer Ma,Sahil Seth,David Torrents,Liu Xi,David A. Wheeler,Carlos López-Otín,Elias Campo,Peter J. Campbell,Paul C. Boutros,Xose S. Puente,Daniela S. Gerhard,Stefan M. Pfister,Stefan M. Pfister,John Douglas Mcpherson,John Douglas Mcpherson,Thomas J. Hudson,Thomas J. Hudson,Matthias Schlesner,Peter Lichter,Roland Eils,Roland Eils,David T. W. Jones,Ivo Gut +93 more
TL;DR: It is shown that using PCR-free methods and increasing sequencing depth to ∼100 × shows benefits, as long as the tumour:control coverage ratio remains balanced, and many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy.
Journal ArticleDOI
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.
Pål Møller,Toni T. Seppälä,Inge Bernstein,Inge Bernstein,Elke Holinski-Feder,Paola Sala,D. Gareth Evans,Annika Lindblom,Finlay A. Macrae,Ignacio Blanco,Rolf H. Sijmons,Jacqueline Jeffries,Hans F. A. Vasen,John Burn,Sigve Nakken,Eivind Hovig,Einar Andreas Rødland,Kukatharmini Tharmaratnam,Wouter H. de Vos tot Nederveen Cappel,James Hill,Juul T. Wijnen,Mark A. Jenkins,Kate Green,Fiona Lalloo,Lone Sunde,Lone Sunde,Miriam Mints,Lucio Bertario,Marta Pineda,Matilde Navarro,Monika Morak,Laura Renkonen-Sinisalo,Ian M. Frayling,John-Paul Plazzer,Kirsi Pylvänäinen,Maurizio Genuardi,Jukka-Pekka Mecklin,Gabriela Möslein,Julian R. Sampson,Gabriel Capellá +39 more
TL;DR: In this paper, the authors address three questions: (i) what is the cumulative incidence of a subsequent cancer; (ii) in which organs do subsequent cancers occur; and (iii) the survival following these cancers? Design Information was collated on prospectively organized surveillance and prospectively observed outcomes in patients with Lynch syndrome who had cancer prior to inclusion and analysed by age, gender and genetic variants.